The infiltration of CD3+CD8+ T cells into the CRC tumor microenvironment (TME) has been reported as an indicator of disease prognosis; higher CD3+CD8+ T-cell infiltrates have been associated with favorable prognosis (2). The gene discussed is CD8A; the disease is neoplasm.